Compass Therapeutics (CMPX) Return on Sales (2024 - 2025)
Compass Therapeutics (CMPX) has disclosed Return on Sales for 2 consecutive years, with 68.85% as the latest value for Q1 2025.
- Quarterly Return on Sales changed N/A to 68.85% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 68.85% through Mar 2025, changed N/A year-over-year, with the annual reading at 66.62% for FY2024, N/A changed from the prior year.
- Return on Sales hit 68.85% in Q1 2025 for Compass Therapeutics, down from 61.97% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 15.38% in Q2 2024 to a low of 68.85% in Q1 2025.